Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 19:00:57 10/12/2024 GMT 		5-day change 1st Jan Change
4.695 USD -2.59% Intraday chart for Vanda Pharmaceuticals Inc. -4.48% +11.14%
11-06 Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q3 Revenue $47.7M MT
11-06 Vanda Pharmaceuticals Inc., Q3 2024 Earnings Call, Nov 06, 2024

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Starts Vanda Pharmaceuticals With Buy Rating, $18 Price Target
10-31
 MT
Cantor Fitzgerald Initiates Vanda Pharmaceuticals at Overweight With $11 Price Target
07-11
 MT
Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24
25/02/22
 MT
VANDA PHARMACEUTICALS : BofA Securities Starts Vanda Pharmaceuticals at Buy With $22 Price Target
12/05/21
 MT
VANDA PHARMACEUTICALS : Citigroup Downgrades Vanda Pharmaceuticals to Neutral From Buy; Price Target is $14
14/01/21
 MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.
  5. Analyst Reco.
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition